Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-19

Clinical Trial Update: Anthrax AV7909 Liquid vs Lyophilized [Phase 1]

View source ↗

Summary

Phase 1 trial comparing liquid versus lyophilized AV7909 anthrax vaccine formulations completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AV7909

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Anthrax, Anthrax Immunisation | Phase 1 | Status: COMPLETED | Results posted: 2024-12-19